Get started
Author

En Chang

Observed names: Chang, En, E Chang
OpenAlex ID: A5071001297
mtDNA-STING Axis Mediates Microglial Polarization via IRF3/NF-κB Signaling After Ischemic Stroke
2022 · Lingqi Kong, Wenyu Li, et al. · Frontiers in Immunology · 178
PDF
Advances of curcumin in nervous system diseases: the effect of regulating oxidative stress and clinical studies
2024 · Yuxun Wei, Hong Li, et al. · Frontiers in Pharmacology · 41
PDF
Safety profiles of methylphenidate, amphetamine, and atomoxetine: analysis of spontaneous reports submitted to the food and drug administration adverse event reporting system
2023 · Wei Wei, Li Chen, et al. · Frontiers in Pharmacology · 22
PDF
Post-marketing safety surveillance of fostamatinib: an observational, pharmacovigilance study leveraging FAERS database
2024 · Wei Wei, Ying-Tao Bai, et al. · Expert Opinion on Drug Safety · 6
The real-world safety of oseltamivir and baloxavir marboxil in children: a disproportionality analysis of the FDA adverse event reporting system
2024 · Wei Wei, Liang Huang, et al. · Frontiers in Pharmacology · 6
PDF
The short- and mid-term efficacy and safety of elagolix in the management of pain associated with endometriosis: A systematic review and meta-analysis
2024 · Yue Zhang, Wei Wei, et al. · Journal of Gynecology Obstetrics and Human Reproduction · 5
Drug-associated hearing impairment in children: a disproportionality analysis of the FDA adverse event reporting system
2025 · Jinfeng Liu, Junyi Tan, et al. · Frontiers in Pharmacology · 2
PDF
Post-marketing safety concerns with luspatercept: a disproportionality analysis of the FDA adverse event reporting system
2025 · Jin-Feng Liu, Ying-Tao Bai, et al. · Expert Opinion on Drug Safety · 2
Effects of Antihypertensive Agents on the Clinical Outcome of Hospitalized COVID-19 Patients Concomitant with Hypertension: A Systematic Review and Meta-Analysis
2023 · Jinfeng Liu, Liang Huang, et al. · Heart & Lung · 2
PDF
Post-marketing safety concerns with elagolix: a disproportionality analysis of the FDA adverse event reporting system
2024 · En Chang, Yong-Fang Shi, et al. · Expert Opinion on Drug Safety · 1
Efcacy and safety of elagolix in moderate to severe endometriosis associated pain: a systematic review and meta analysis
2023 · Jinfeng Liu, Wei Wei, et al.
PDF
Works count: 14
Citation count: 265
H-index: 5
I10-index: 3
Year
Topic
Type